PanGenomic Health Inc. CSE: NARA, is pleased to announce, further to its news releases dated September 1, 2022 and November 21, 2022, the completion of its previously announced acquisition (the “Transaction”) of Mindleap Health Inc. from Mydecine Innovations Group Inc., a company listed on the NEO Exchange. “We are excited about the acquisition of Mindleap as it represents…